Gain Therapeutics, Inc. Common Stock — Institutional Ownership
Which tracked institutions hold GANX, and how they changed the position last quarter. Latest holdings as of Mar 31, 2026. Source: SEC 13-F filings.
5
Funds holding
$1255727
Total value held
Buying
3 added/new · 1 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Blackrock, Inc. | $436589 | 225046 | +15467 | +7.38% |
| 2 | State Street Corp | $305622 | 157537 | — | Held |
| 3 | Morgan Stanley | $270925 | 139652 | -7939 | -5.38% |
| 4 | Northern Trust Corp | $221154 | 113997 | +11996 | +11.76% |
| 5 | Wells Fargo & Company/Mn | $21437 | 11050 | +8400 | +316.98% |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.